Basic pharmacokinetic data concerning a new active substance are required in the context of assessment of the clinical safety and efficacy of the veterinary medicinal product.
Is gá bunsonraí cógaschinéiteacha a sholáthar maidir le substaint ghníomhach nua i gcomhthéacs mheasúnú na sábháilteachta cliniciúla agus éifeachtúlacht an táirge íocshláinte tréidliachta.